| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.24 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |